Gemcitabine pulmonary toxicity in ovarian cancer.
A case of gemcitabine-induced lung toxicity is reported in a woman with stage IIIc ovarian papillary serous carcinoma. An 83-year-old woman with stage IIIc ovarian serous papillary carcinoma diagnosed in 2001 underwent suboptimal cytoreductive surgery followed by carboplatin-paclitaxel chemotherapy. Initially in remission following chemotherapy, the disease subsequently progressed over the next 5 years. The patient received gemcitabine palliative chemotherapy. She developed significant pulmonary toxicity consistent with drug-induced interstitial pneumonitis, which improved with steroid therapy. Gemcitabine, a second-line chemotherapy agent for the treatment of ovarian cancer, may rarely cause a serious or even fatal condition of pulmonary lung toxicity.